Meilian Dong

484 total citations
17 papers, 369 citations indexed

About

Meilian Dong is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Meilian Dong has authored 17 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Meilian Dong's work include Bone health and treatments (3 papers), MicroRNA in disease regulation (3 papers) and Advanced Radiotherapy Techniques (3 papers). Meilian Dong is often cited by papers focused on Bone health and treatments (3 papers), MicroRNA in disease regulation (3 papers) and Advanced Radiotherapy Techniques (3 papers). Meilian Dong collaborates with scholars based in China. Meilian Dong's co-authors include Yonggang Shi, Xiaobin Gu, Jiang Li, Jing Yang, Ruitai Fan, Jing Yang, Zhigang Zhang, Yue Zhang, Li Jiang and Yue Zhang and has published in prestigious journals such as Scientific Reports, Medicine and Cell Death and Disease.

In The Last Decade

Meilian Dong

16 papers receiving 363 citations

Peers

Meilian Dong
Comparison fields: 5 of 55
  • Oncology 172
  • Cancer Research 134
  • Molecular Biology 121
  • Immunology 82
  • Pulmonary and Respiratory Medicine 51
Replace Yalun Li with:
Yalun Li China
Longhao Sun China
Giacomo Santandrea Italy
Nima Mesbah Ardakani Australia
Sotirios Lakis Greece
Laura Mansi France
Damian J. Ralser Germany
Zhongqiu Lin China
Félix Blanc‐Durand France
Irene Papaspyrou Greece
Yalun Li China View profile →
Citations per field, relative to Meilian Dong
Meilian Dong · 1×
Citations per year, relative to Meilian Dong
Meilian Dong · 1×

Countries citing papers authored by Meilian Dong

Since Specialization
Citations

This map shows the geographic impact of Meilian Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meilian Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meilian Dong more than expected).

Fields of papers citing papers by Meilian Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meilian Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meilian Dong. The network helps show where Meilian Dong may publish in the future.

Co-authorship network of co-authors of Meilian Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Meilian Dong. A scholar is included among the top collaborators of Meilian Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meilian Dong. Meilian Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
# Work Indexed citations
1 0
2 4
3 64
4 8
5 9
6 22
7 24
8 70
9 48
10 7
11 13
12 12
13 9
14
Hypoxia responsive miR-210 promotes cell survival and autophagy of endometriotic cells in hypoxia.
44
15 2
16 20
17 13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026